The total amount is \u00a58,893,430 for 23,590 stock acquisition rights allocated to Cantor Fitzgerald Europe, generating 2,359,000 potential shares. The exercise price starts at \u00a5847.8, and after the adjustment date it is updated weekly to a level close to 90% of the prior week\u2019s closing price, with no upper limit. The use of funds is for operating funds of \u00a51,499 million and R&D funds of \u00a5500 million. The offering period runs from 2026-08-24 to 2029-08-23. Dilution is expected to be about 58.79%, but the move is intended to support mid-to long-term business expansion and competitiveness. The Independent Committee\u2019s opinion has deemed the fairness of the measure.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"6656","jir_company_name":"Inspec Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-08-05","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/08\/6656-20260805-01.pdf","jir_short_summary":"The total amount is \u00a58,893,430 for 23,590 stock acquisition rights allocated to Cantor Fitzgerald Europe, generating 2,359,000 potential shares. The exercise price starts at \u00a5847.8, and after the adjustment date it is updated weekly to a level close to 90% of the prior week\u2019s closing price, with no upper limit. The use of funds is for operating funds of \u00a51,499 million and R&D funds of \u00a5500 million. The offering period runs from 2026-08-24 to 2029-08-23. Dilution is expected to be about 58.79%, but the move is intended to support mid-to long-term business expansion and competitiveness. The Independent Committee\u2019s opinion has deemed the fairness of the measure.","jir_summary":"### Overview of funding\nInspec allocates the 19th stock acquisition right by third-party allotment to Cantor Fitzgerald Europe, raising funds through exercise. The total is \u00a58,893,430, with 23,590 rights issued and 2,359,000 shares underlying, resulting in an anticipated maximum dilution of 58.79%. The exercise price starts at \u00a5847.8, with weekly adjustments on the adjustment date to an amount equivalent to 90% of the previous week\u2019s close, and there is no upper limit to the price.\n\n### Use of funds and strategic background\nFunds are planned to be used for operating funds of \u00a51,499 million and R&D funds of \u00a5500 million, totaling \u00a51,999 million. The primary business is semiconductor package substrate inspection equipment, with expansion of AIDC investments and rising component costs leading to increased working capital. Continued development including SX7000\/LX7000 deployment and advanced AI image processing to maintain and strengthen competitiveness. As the exposure equipment business is exited, funding needs have been reorganized, and dynamic funding is deemed necessary.","jir_financial_highlights":"Issued shares total: 4,012,800 shares (unknown)\nPotential shares: 2,359,000 shares (unknown)\nDilution rate: 58.79% (unknown)\nTotal paid-in amount: \u00a58,893,430 (unknown)\nEstimated net proceeds after deduction: \u00a51,999,103,630 (unknown)","jir_category":"","jir_hashtags":"#Inspec Co., Ltd., #StockOptions, #CapitalPolicy","jir_key_figures":"Stock options total: 23,590\nPotential shares: 2,359,000 shares\nDilution rate: 58.79%","jir_meta_title":"\u3010Inspec Co., Ltd.\u3011Notice of Stock Acquisition Rights Issuance\uff5cAugust 2026","jir_meta_description":"Inspec issues the 19th stock acquisition rights to Cantor Fitzgerald Europe through a third-party allotment. Funds used for operating funds of \u00a51,499 million and R&D funds of \u00a5500 million, with a dilution of about 58.79%. Detailed explanation provided.","jir_og_title":"Inspec: Notice of Stock Acquisition Rights Issuance\uff5cAugust 2026","jir_og_description":"Summary of stock acquisition rights allocation and exercise conditions, use of funds, and dilution impact. Explains future business expansion and flexibility of capital policy.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":61081,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"share_option","footnotes":""},"sector":[],"importance":[],"class_list":["post-95892","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n